{
    "sourceOrganization": [
        {
            "@type": "ResearchProject",
            "name": "NIAID CoVPN Network",
            "abstract": "NIAID established the COVID-19 Prevention Network (CoVPN) to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19. The CoVPN merges four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network (HVTN), the HIV Prevention Trials Network (HPTN), the Infectious Diseases Clinical Research Consortium (IDCRC), and the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG).",
            "description": "The COVID-19 Prevention Network (CoVPN) was established by NIAID to enroll thousands of volunteers in large-scale clinical trials evaluating investigational COVID-19 vaccines and monoclonal antibodies. It brings together four NIAID-funded clinical trials networks to accelerate the development of prevention strategies. For more information, visit the NIAID program page: https://www.niaid.nih.gov/diseases-conditions/coronavirus-vaccines-prevention",
            "alternateName": [
                "The COVID-19 Prevention Network",
                "CoVPN"
            ],
            "url": "https://www.coronaviruspreventionnetwork.org/",
            "parentOrganization": [
                "NIAID"
            ]
        }
    ],
    "fundingIdentifiers": [
        "AI068614",
        "AI068618",
        "AI068635",
        "AI068619",
        "AI148689",
        "AI068636",
        "AI068617",
        "AI148685",
        "NR020834"
    ]
}